Therapy-induced senescence associated secretory phenotype enhances breast cancer cell invasion and stemness via CXCR1/2-CXCR1/2 ligands axis

被引：0
|
作者：
Choi, Yong Won [1 ]
Cha, Hyun-Young [1 ]
Park, Tae Jun [1 ]
Ahn, Mi Sun [1 ]
Lee, Hyun Woo [1 ]
Jeong, Seong Hyun [1 ]
Kang, Seok Yun [1 ]
Park, Joon Seong [1 ]
Choi, Jin-Hyuk [1 ]
机构：
[1] Ajou Univ, Sch Med, Suwon, South Korea
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-469
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
469
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Nonapical and cytoplasmic expression of interleukin-8, CXCR1, and CXCR2 correlates with cell proliferation and microvessel density in prostate cancer
    Murphy, C
    McGurk, M
    Pettigrew, J
    Santinelli, A
    Mazzucchelli, R
    Johnston, PG
    Montironi, R
    Waugh, DJJ
    CLINICAL CANCER RESEARCH, 2005, 11 (11) : 4117 - 4127
  • [22] IL-8/CXCR1/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastoma
    Sharma, Ira
    Singh, Avninder
    Siraj, Fouzia
    Saxena, Sunita
    JOURNAL OF BIOMEDICAL SCIENCE, 2018, 25
  • [23] IL-8/CXCR1/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastoma
    Ira Sharma
    Avninder Singh
    Fouzia Siraj
    Sunita Saxena
    Journal of Biomedical Science, 25
  • [24] Sustained CXCR2 signaling promotes secretory phenotype in cancer-associated fibroblasts of pancreatic cancer via activation of NFkB
    Awaji, Mohammad
    Varney, Michelle
    Purohit, Abhilasha
    Wu, Lingyun
    Saxena, Sugandha
    Kumar, Sushi
    Batra, Surinder K.
    Singh, Rakesh K.
    CANCER RESEARCH, 2019, 79 (13)
  • [25] A window-of-opportunity trial of the CXCR1/2 inhibitor reparixin in operable HER-2-negative breast cancer
    Goldstein, Lori J.
    Perez, Raymond P.
    Yardley, Denise
    Han, Linda K.
    Reuben, James M.
    Gao, Hui
    McCanna, Susan
    Butler, Beth
    Ruffini, Pier Adelchi
    Liu, Yi
    Rosato, Roberto R.
    Chang, Jenny C.
    BREAST CANCER RESEARCH, 2020, 22 (01)
  • [26] Expression of chemokines IL-8 and GCP-2 and their receptors CXCR1 and CXCR2 in small and non-small cell lung cancer cell lines
    Zhu, YM
    Flower, D
    Woll, PJ
    BRITISH JOURNAL OF CANCER, 2004, 91 : S69 - S69
  • [27] Role of IL8-CXCR1/2 axis in glioblastoma cell proliferation, invasion, and vascular mimicry
    Sharma, Ira
    Singh, Avninder
    Siraj, Fouzia
    Saxena, Sunita
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [28] Value of CXCL8–CXCR1/2 axis in neoadjuvant chemotherapy for triple-negative breast cancer patients: a retrospective pilot study
    Ruo-Xi Wang
    Peng Ji
    Yue Gong
    Zhi-Ming Shao
    Sheng Chen
    Breast Cancer Research and Treatment, 2020, 181 : 561 - 570
  • [29] Targeting CXCR1/2 Significantly Reduces Breast Cancer Stem Cell Activity and Increases the Efficacy of Inhibiting HER2 via HER2-Dependent and -Independent Mechanisms
    Singh, Jagdeep K.
    Farnie, Gillian
    Bundred, Nigel J.
    Simoes, Bruno M.
    Shergill, Amrita
    Landberg, Goeran
    Howell, Sacha J.
    Clarke, Robert B.
    CLINICAL CANCER RESEARCH, 2013, 19 (03) : 643 - 656
  • [30] HIF-1 and NF-κB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells
    Maxwell, P. J.
    Gallagher, R.
    Seaton, A.
    Wilson, C.
    Scullin, P.
    Pettigrew, J.
    Stratford, I. J.
    Williams, K. J.
    Johnston, P. G.
    Waugh, D. J. J.
    ONCOGENE, 2007, 26 (52) : 7333 - 7345
12345